Fortis Healthcare (BOM:532843) Tariff Resilience Score: 0/10 (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532843 Fortis Healthcare Ltd BOM:532843
86 GF Score
Price ₹925.60
GF Value ₹815.76
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Fortis Healthcare Tariff Resilience Score?

Fortis Healthcare has the Tariff Resilience Score of 0, which implies that the company might have .

Fortis Healthcare has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Fortis Healthcare might have .

Fortis Healthcare  (BOM:532843) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Fortis Healthcare Tariff Resilience Score Related Terms

BOM:532843
86GF Score
Fortis Healthcare Ltd BOM:532843
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fortis Healthcare (BOM:532843) Overvalued in 2026?

Based on GuruFocus' analysis, Fortis Healthcare stock appears to be overvalued. The current stock price of ₹925.60 is trading 13.5% above its estimated GF Value™ of ₹815.76. GuruFocus considers Fortis Healthcare to be Modestly Overvalued.

Key valuation signals for BOM:532843:

  • Tariff Resilience Score: 0
  • GF Value™: ₹815.76 vs. price of ₹925.60 (13.5% above fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the BOM:532843 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortis Healthcare Business Description

Other Exchanges FORTIS:India
Address Block - F, South City 1, Sector - 41, Tower-A, Unitech Business Park, Gurgaon, HR, IND, 122001
Fortis Healthcare Ltd provides integrated healthcare delivery services in India. The company manages healthcare centers including hospitals, diagnostics, and day care specialty facilities. The company's key specialty in its hospital business is cardiac sciences. It is predominantly engaged in the business of healthcare services which is the only reportable segment. The company's key hospitals include Fortis Escorts Heart Institute in Dehli, Fortis Mulund in Mumbai, and Fortis Hospital in Bengaluru. The majority of the company's revenue is derived from India.
86GF Score

Get the complete analysis for BOM:532843

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹925.60
Price
₹815.76
GF Value